Specific Immunotherapy With Recombinant Birch Pollen Allergen rBet v1-FV

Clinical trial NCT00266526 · COMPLETED

Trial details

NCT number: NCT00266526
Sponsor: Allergopharma GmbH & Co. KG
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Birch Pollen Allergy

Start date: 2003-07-01
Primary completion: 2004-07-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.